Corpus ID: 31231674

Anaplastic Thyroid Cancer: a Retrospective analysis of 120 cases.

  title={Anaplastic Thyroid Cancer: a Retrospective analysis of 120 cases.},
  author={M. Aldehaim and R. Mahmood and F. Hussain and A. Memon and A. Al-Hebshi and N. Al-Rajhi and M. El-Sebaie and E. Khalil and M. Ahmad},
  journal={The Gulf journal of oncology},
  volume={1 15},
INTRODUCTION Anaplastic Thyroid Cancer (ATC) is one of the most lethal malignancies with very short survival and extremely poor treatment outcome. ATC accounts for 2-5% of all thyroid cancers worldwide with an annual incidence of about 2 million. OBJECTIVE To review the natural history and treatment outcome of ATC patients treated at King Faisal Specialist Hospital and Research Centre (KFSH and RC) located at Riyadh, Saudi Arabia. MATERIAL AND METHODS Retrospective review of 120 Saudi… Expand
Treatment Outcomes in Anaplastic Thyroid Cancer
Anaplastic thyroid cancer patients receiving EBRT to the thyroid area/neck and/or surgical resection had better OS than patients without these therapies, though selection bias likely contributed to improved outcomes since patients who can undergo these therapies tend to have better performance status. Expand
Anaplastic thyroid carcinoma: Failure of conventional therapy but hope of targeted therapy
The purpose of the study was to evaluate the outcomes of patients with anaplastic thyroid cancer in Ireland and to establish a smoking ban in patients diagnosed with the disease. Expand
Elastic Scattering Spectroscopy for Thyroid Disease
The thyroid gland is anatomically located in the neck, just below the laryngeal prominence, or what’s more commonly referred to as the “Adam’s apple.” The thyroid is a bilobed, butterfly-shaped organExpand


Anaplastic Thyroid Cancer: A Review of Epidemiology, Pathogenesis, and Treatment
A comprehensive literature search using PubMed focusing on the treatment of anaplastic thyroid cancer including historical review of treatment and outcomes and investigations of new agents and approaches is performed. Expand
Multimodal therapeutic approach in anaplastic thyroid cancer
This work reviewed the medical records of 15 patients diagnosed with ATC in this institution between 1988 and 2003 to identify prognostic factors of this disease and analyzed treatment outcomes in patients with A TC. Expand
Multimodal therapeutic approach in anaplastic thyroid cancer.
Although most patients with ATC had a poor prognosis, a multimodal approach including surgery, radiotherapy and chemotherapy, might improve survival. Expand
Anaplastic thyroid cancer in British Columbia 1985-1999: a population-based study.
Long-term, disease-free survival was achieved in a few patients who were able to receive high-dose radiotherapy, preferably after adequate surgery. Expand
Anaplastic carcinoma of the thyroid: A clinicopathologic study of 121 cases
One hundred twenty‐one cases of anaplastic carcinoma of the thyroid treated at M. D. Anderson Cancer Center, Houston, were reviewed, and a significant percentage of patients (35%) had areas of well‐differentiated thyroid carcinoma elsewhere, supporting the hypothesis that anaPlastic thyroid carcinomas arises from preexisting well-differentiated Thyroid Carcinoma. Expand
Multimodality treatment for anaplastic thyroid carcinoma--treatment outcome in 75 patients.
Despite the ultimately dismal prognosis of ATC-patients, multimodality treatment significantly improved local control and improved the median survival. Expand
Trend in thyroid carcinoma size, age at diagnosis, and histology in a retrospective study of 500 cases diagnosed over 20 years.
The temporal trend in tumor size, age at diagnosis, and histology in a retrospective analysis of 500 thyroid cancers diagnosed over 20 years confirmed the importance of evaluating thyroid nodules smaller than 10mm and corroborate recent findings suggesting that age be reconsidered as an independent prognostic factor for differentiated thyroid cancers. Expand
Anaplastic thyroid carcinoma: 91 patients treated by surgery and radiotherapy.
  • E. Junor, J. Paul, N. Reed
  • Medicine
  • European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology
  • 1992
Results show dyspnoea to be the only symptom strongly influencing survival, and total or partial thyroidectomy is associated with increased survival, most marked for patients presenting without dysPNoea. Expand
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
  • E. Cohen, L. Rosen, +11 authors R. Cohen
  • Medicine
  • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
  • 2008
Axitinib is a selective inhibitor of VEGFR with compelling antitumor activity in all histologic subtypes of advanced thyroid cancer. Expand
Anaplastic thyroid carcinoma
Analyzing prognostic factors and treatment outcomes in patients with ATC reported in the National Cancer Institute's Surveillance, Epidemiology, and End Results data base concluded that aggressive multimodal therapy in selected patients may improve survival. Expand